Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_provenance.
- NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_assertion wasGeneratedBy ECO_0000203 NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_provenance.
- NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_assertion wasDerivedFrom befree-20140225 NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_provenance.
- NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_assertion SIO_000772 19440200 NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_provenance.
- NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_assertion evidence source_evidence_literature NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_provenance.
- NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_assertion description "[We have found that seven of these genes exhibit a significant (FDR<0.05) association with SLE, both confirming some genes that have earlier been found to be associated with SLE (PTPN22 and IRF5) and presenting novel findings of genes (KLRG1, interleukin-16, protein tyrosine phosphatase receptor type T, toll-like receptor (TLR)8 and CASP10), which have not been reported earlier.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_provenance.
- befree-20140225 importedOn "2014-02-25" NP301959.RAO69vcfDW-nZkYSj9O2Xysy9oc7LZDRM3jFPwqtq8-Ro130_provenance.